{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:10:02Z","timestamp":1790680202439,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["2015270"],"award-info":[{"award-number":["2015270"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>There is a need to assess the quality of treatment for Substance Use Disorder (SUD), and document SUD patients\u2019 health-related quality of life (HRQoL). The study aims to describe Norwegian SUD patients\u2019 HRQoL as measured by EQ-5D, compared to a general population sample, and discuss the potential usefulness of the EQ-5D to monitor HRQoL for SUD patients.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred seventy eight SUD patients (66.3% male) were administered the EQ-5D-3L at treatment start. Patients and general population samples were compared in terms of reported EQ-5D-3L health states, problems by dimension, UK index values, and EQ VAS scores. We investigated specific drug dependence, mental health disorders, sex, age, and education as predictors of EQ-5D-3L values and EQ VAS scores. Anxiety\/depression dimension scores were compared to Hopkins symptom Checklist (HSCL-25) scores.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>91.6% of the patient sample reported problems on the EQ-5D-3L, with 29.8% reporting extreme problem, compared to 39.8% and 3.0% in the general population sample. Mean index (EQ VAS) score among SUD patients was .59 (59.9) compared to .90 (84.1) in the general population. Regression analyses identified phobic anxiety and cocaine dependence as statistically significant predictors of higher EQ-5D-3L index scores.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SUD patients report substantially reduced HRQoL, as measured using the EQ-5D-3L. The most frequently reported problems were for the anxiety\/depression, pain\/discomfort, and usual activities dimensions. The EQ-5D may be a useful and practical instrument for monitoring HRQoL in SUD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-020-00247-0","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T12:06:38Z","timestamp":1604923598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-4099","authenticated-orcid":false,"given":"Kim","family":"Rand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-0017","authenticated-orcid":false,"given":"Espen Ajo","family":"Arnevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-9596","authenticated-orcid":false,"given":"Espen","family":"Walderhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"247_CR1","volume-title":"Drug misuse:-psychosocial interventions (NICE clinical guidelines CG51)","author":"National Collaborating Centre for Mental Health","year":"2007","unstructured":"National Collaborating Centre for Mental Health (2007). Drug misuse:-psychosocial interventions (NICE clinical guidelines CG51). London: National Institute of Health and Care Excellence."},{"issue":"6","key":"247_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000350740","volume":"19","author":"MP Schaub","year":"2013","unstructured":"Schaub, M. P., & Uchtenhagen, A. (2013). Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction. European Addiction Research, 19(6), 314\u2013324.","journal-title":"European Addiction Research"},{"issue":"3","key":"247_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"Whoqol Group","year":"1998","unstructured":"Whoqol Group (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551\u2013558.","journal-title":"Psychological Medicine"},{"key":"247_CR4","first-page":"1","volume-title":"Applied health economics and health policy","author":"NJ Devlin","year":"2017","unstructured":"Devlin, N. J., & Brooks, R. (2017). EQ-5D and the EuroQol group: Past, present and future. In Applied health economics and health policy, (pp. 1\u201311)."},{"key":"247_CR5","doi-asserted-by":"publisher","unstructured":"Walderhaug, E., Seim-Wikse, K. J., Enger, A., & Milin, O. (2019). Polydrug use \u2013 Prevalence and registration. Tidsskrift for Den norske legeforening. https:\/\/doi.org\/10.4045\/tidsskr.19.0251.","DOI":"10.4045\/tidsskr.19.0251"},{"issue":"1","key":"247_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12955-018-1029-1","volume":"16","author":"K Stavem","year":"2018","unstructured":"Stavem, K., Augestad, L. A., Kristiansen, I. S., & Rand, K. (2018). General population norms for the EQ-5D-3 L in Norway: Comparison of postal and web surveys. Health and Quality of Life Outcomes, 16(1), 204. https:\/\/doi.org\/10.1186\/s12955-018-1029-1.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"247_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R., & EuroQol Group (1996). EuroQol: The current state of play. Health Policy, 37(1), 53\u201372.","journal-title":"Health Policy"},{"key":"247_CR8","unstructured":"EuroQol Group (1990). EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy, 16(3)."},{"key":"247_CR9","doi-asserted-by":"crossref","unstructured":"Wisl\u00f8ff, T., Hagen, G., Hamidi, V., Movik, E., Klemp, M., & Olsen, J. A. (2014). Estimating QALY gains in applied studies: A review of cost-utility analyses published in 2010. PharmacoEconomics, 32(4), 367\u2013375.","DOI":"10.1007\/s40273-014-0136-z"},{"key":"247_CR10","doi-asserted-by":"crossref","unstructured":"Rowen, D., Zouraq, I. A., Chevrou-Severac, H., & van Hout, B. (2017). International regulations and recommendations for utility data for health technology assessment. Pharmacoeconomics, 35(1), 11\u201319.","DOI":"10.1007\/s40273-017-0544-y"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s11136-016-1375-6","volume":"25","author":"F Rencz","year":"2016","unstructured":"Rencz, F., Gul\u00e1csi, L., Drummond, M., Golicki, D., Rupel, V. P., Simon, J., et al. (2016). EQ-5D in central and Eastern Europe: 2000-2015. Quality of life research : An international journal of quality of life aspects of treatment, care and rehabilitation. Quality of Life Research, 25, 2693\u20132710. https:\/\/doi.org\/10.1007\/s11136-016-1375-6.","journal-title":"Quality of Life Research"},{"key":"247_CR12","doi-asserted-by":"crossref","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., \u2026 Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 1\u201310.","DOI":"10.1007\/s11136-011-9903-x"},{"issue":"7","key":"247_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s001270050064","volume":"33","author":"I Sandanger","year":"1998","unstructured":"Sandanger, I., Moum, T., Ingebrigtsen, G., Dalgard, O. S., S\u00f8rensen, T., & Bruusgaard, D. (1998). Concordance between symptom screening and diagnostic procedure: The Hopkins symptom Checklist-25 and the composite international diagnostic interview I. Social Psychiatry and Psychiatric Epidemiology, 33(7), 345\u2013354.","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"11","key":"247_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095.","journal-title":"Medical Care"},{"key":"247_CR15","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"Core Team, R. (2016). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing Retrieved from https:\/\/www.R-project.org\/."},{"key":"247_CR16","unstructured":"Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis. 2nd ed.  New York, NY. Springer."},{"issue":"5","key":"247_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1192\/bjp.bp.109.076489","volume":"197","author":"SI Saarni","year":"2010","unstructured":"Saarni, S. I., Vierti\u00f6, S., Per\u00e4l\u00e4, J., Koskinen, S., L\u00f6nnqvist, J., & Suvisaari, J. (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. The British Journal of Psychiatry, 197(5), 386\u2013394. https:\/\/doi.org\/10.1192\/bjp.bp.109.076489.","journal-title":"The British Journal of Psychiatry"},{"issue":"2","key":"247_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5617\/njhe.2413","volume":"4","author":"AV Olesen","year":"2016","unstructured":"Olesen, A. V., Oddershede, L., & Petersen, K. D. (2016). Health-related quality of life in Denmark on a relative scale: Mini-catalogue of mean EQ-5D-3L index scores for 17 common chronic conditions. Nordic Journal of Health Economics, 4(2), 44.","journal-title":"Nordic Journal of Health Economics"},{"issue":"1","key":"247_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-5-70","volume":"5","author":"AS Pickard","year":"2007","unstructured":"Pickard, A. S., Neary, M. P., & Cella, D. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes, 5(1), 70. https:\/\/doi.org\/10.1186\/1477-7525-5-70.","journal-title":"Health and Quality of Life Outcomes"},{"key":"247_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsat.2017.01.016","volume":"76","author":"E Hagen","year":"2017","unstructured":"Hagen, E., Erga, A. H., Hagen, K. P., Nesv\u00e5g, S. M., McKay, J. R., Lundervold, A. J., & Walderhaug, E. (2017). One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. Journal of Substance Abuse Treatment, 76, 81\u201387. https:\/\/doi.org\/10.1016\/j.jsat.2017.01.016.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"247_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.drugalcdep.2007.07.016","volume":"92","author":"OH G\u00fcnther","year":"2008","unstructured":"G\u00fcnther, O. H., Roick, C., Angermeyer, M. C., & K\u00f6nig, H.-H. (2008). Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug and Alcohol Dependence, 92(1), 291\u2013295. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.07.016.","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"247_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.drugalcdep.2005.08.012","volume":"82","author":"BP van der Zanden","year":"2006","unstructured":"van der Zanden, B. P., Dijkgraaf, M. G. W., Blanken, P., de Borgie, C. A. J. M., van Ree, J. M., & van den Brink, W. (2006). Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug and Alcohol Dependence, 82(2), 111\u2013118. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.08.012.","journal-title":"Drug and Alcohol Dependence"},{"key":"247_CR23","doi-asserted-by":"publisher","unstructured":"Dalen, E., Holmen, J., & Nordahl, H. M. (2015). Somatic health of patients at an outpatient clinic for substance abuse. Tidsskrift for Den norske legeforening. https:\/\/doi.org\/10.4045\/tidsskr.13.0801.","DOI":"10.4045\/tidsskr.13.0801"},{"issue":"8","key":"247_CR24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","volume":"33","author":"HH Brorson","year":"2013","unstructured":"Brorson, H. H., Arnevik, E. A., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 33(8), 1010\u20131024.","journal-title":"Clinical Psychology Review"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-020-00247-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41687-020-00247-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-020-00247-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:14:26Z","timestamp":1604967266000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-020-00247-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1186\/s41687-020-00247-0","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"27 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Collection of data from patients reported in this paper were approved by the Norwegian Data Protection Official for Research (10\/01172\u20132), the Norwegian Regional Committees for Medical Research Ethics, south-eastern region B; 2017\/1536, and the Oslo University Hospital Data Protection Official; 2017\/15842. All patient participants signed a written informed consent.The general population data was collected in a parallel postal and web-based survey of the Norwegian population between May 10th and June 22nd 2010. The study was designed to provide a representative sample of the adult Norwegian population in terms of age, sex, and educational level. The study was considered outside the jurisdiction of the Regional Committee for Medical Health Research Ethics, and ethical approval was obtained from the Data Protection Official at Akershus University Hospital April 27th 2010. Further detail can be obtained in [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KR is a member of the EuroQol Group, a not-for-profit research foundation which develops, owns, and licenses the EQ-5D. The EuroQol Group has no involvement with the study beyond funding. No other competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}